BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6415182)

  • 1. Reactogenicity, immunogenicity, and efficacy of a chick embryo cell-derived vaccine for Rocky Mountain spotted fever.
    Clements ML; Wisseman CL; Woodward TE; Fiset P; Dumler JS; McNamee W; Black RE; Rooney J; Hughes TP; Levine MM
    J Infect Dis; 1983 Nov; 148(5):922-30. PubMed ID: 6415182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of vaccination schedule on immune response of Macaca mulatta to cell culture-grown Rocky Mountain spotted fever vaccine.
    Sammons LS; Kenyon RH; Pedersen CE
    J Clin Microbiol; 1976 Sep; 4(3):253-7. PubMed ID: 823173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-mediated immune responses of adults to vaccination, challenge with Rickettsia rickettsii, or both.
    Dumler JS; Wisseman CL; Fiset P; Clements ML
    Am J Trop Med Hyg; 1992 Feb; 46(2):105-15. PubMed ID: 1539743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a killed Rocky Mountain spotted fever vaccine in cynomolgus monkeys.
    Gonder JC; Kenyon RH; Pedersen CE
    J Clin Microbiol; 1979 Nov; 10(5):719-23. PubMed ID: 120877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rocky Mountain spotted fever vaccine: a regional need.
    Walker DH; Montenegro MR; Hegarty BC; Tringali GR
    South Med J; 1984 Apr; 77(4):447-9. PubMed ID: 6424239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New assay of protective activity of Rocky Mountain spotted fever vaccines.
    Anacker RL; Smith RF; Mann RE; Hamilton MA
    J Clin Microbiol; 1976 Sep; 4(3):309-11. PubMed ID: 823177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rocky Mountain spotted fever vaccine in an animal model.
    Folds JD; Walker DH; Hegarty BC; Banasiak D; Lange JV
    J Clin Microbiol; 1983 Aug; 18(2):321-6. PubMed ID: 6413529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of Rocky Mountain spotted fever vaccine suitable for human immunization.
    Kenyon RH; Pedersen CE
    J Clin Microbiol; 1975 Jun; 1(6):500-3. PubMed ID: 809483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of three rocky mountain spotted fever vaccines.
    Kenyon RH; Sammons LS; Pedersen CE
    J Clin Microbiol; 1975 Oct; 2(4):300-4. PubMed ID: 810494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial clinical evaluation of a new Rocky Mountain spotted fever vaccine of tissue culture origin.
    Ascher MS; Oster CN; Harber PI; Kenyon RH; Pedersen CE
    J Infect Dis; 1978 Aug; 138(2):217-21. PubMed ID: 355580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A recombinant Rickettsia conorii vaccine protects guinea pigs from experimental boutonneuse fever and Rocky Mountain spotted fever.
    Vishwanath S; McDonald GA; Watkins NG
    Infect Immun; 1990 Mar; 58(3):646-53. PubMed ID: 2106490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serodiagnosis of Rocky Mountain spotted fever: comparison of IgM and IgG enzyme-linked immunosorbent assays and indirect fluorescent antibody test.
    Clements ML; Dumler JS; Fiset P; Wisseman CL; Snyder MJ; Levine MM
    J Infect Dis; 1983 Nov; 148(5):876-80. PubMed ID: 6415180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rickettsia rickettsii Whole-Cell Antigens Offer Protection against Rocky Mountain Spotted Fever in the Canine Host.
    Alhassan A; Liu H; McGill J; Cerezo A; Jakkula LUMR; Nair ADS; Winkley E; Olson S; Marlow D; Sahni A; Narra HP; Sahni S; Henningson J; Ganta RR
    Infect Immun; 2019 Feb; 87(2):. PubMed ID: 30396898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rocky Mountain spotted fever in children in Kansas: the diagnostic value of an IgM-specific immunofluorescence assay.
    Hays PL
    J Infect Dis; 1985 Feb; 151(2):369-70. PubMed ID: 3918126
    [No Abstract]   [Full Text] [Related]  

  • 15. Extraction of protective components of Rickettsia rickettsii with n-octyl-beta-D-glucopyranoside.
    McDonald GA; Anacker RL; Mann RE
    Rev Infect Dis; 1988; 10 Suppl 2():S382-5. PubMed ID: 3142019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rocky Mountain spotted fever: a comparative study of the active immunity induced by inactivated and viable pathogenic Rickettsia rickettsii.
    DuPont HL; Hornick RB; Dawkins AT; Heiner GG; Fabrikant IB; Wisseman CL; Woodward TE
    J Infect Dis; 1973 Sep; 128(3):340-4. PubMed ID: 4199563
    [No Abstract]   [Full Text] [Related]  

  • 17. "Rickettsia amblyommii" induces cross protection against lethal Rocky Mountain spotted fever in a guinea pig model.
    Blanton LS; Mendell NL; Walker DH; Bouyer DH
    Vector Borne Zoonotic Dis; 2014 Aug; 14(8):557-62. PubMed ID: 25072985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface protein Adr2 of Rickettsia rickettsii induced protective immunity against Rocky Mountain spotted fever in C3H/HeN mice.
    Gong W; Xiong X; Qi Y; Jiao J; Duan C; Wen B
    Vaccine; 2014 Apr; 32(18):2027-33. PubMed ID: 24582636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced protection against Rickettsia rickettsii infection in C3H/HeN mice by immunization with a combination of a recombinant adhesin rAdr2 and a protein fragment rOmpB-4 derived from outer membrane protein B.
    Gong W; Wang P; Xiong X; Jiao J; Yang X; Wen B
    Vaccine; 2015 Feb; 33(8):985-92. PubMed ID: 25597943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of monoclonal antibodies protecting mice against Rickettsia rickettsii.
    Anacker RL; List RH; Mann RE; Hayes SF; Thomas LA
    J Infect Dis; 1985 Jun; 151(6):1052-60. PubMed ID: 3923129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.